Celularity Inc.
Income Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $4.1M | $5.3M | $5.7M | $11.4M | $18.1M | $9.3M | $12.1M |
| Cost of Revenue | $1.5M | $7.4M | $3.9M | $5.2M | $3.6M | $7.3M | $3.9M | $2.1M |
| Gross Profit | $2.4M | $-3.3M | $1.4M | $494.0K | $7.9M | $10.8M | $5.4M | $10.0M |
| Gross Margin | 62.2% | -79.7% | 26.1% | 8.6% | 68.9% | 59.5% | 58.2% | 82.5% |
| Operating Expenses | ||||||||
| Research & Development | $3.0M | $3.3M | $4.6M | $3.4M | $3.7M | $3.8M | $3.9M | $3.8M |
| SG&A Expense | $9.2M | $15.1M | $9.3M | $12.6M | $14.3M | $16.1M | $12.7M | $15.9M |
| Operating Income | $-10.1M | $-22.1M | $-12.9M | $-15.9M | $-10.5M | $-9.3M | $-11.5M | $-10.2M |
| Operating Margin | -263.5% | -537.5% | -244.1% | -276.6% | -91.8% | -51.2% | -124.0% | -84.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $874.0K | $-24.4M | $-23.1M | $-24.5M | $-19.8M | $-13.3M | $-16.1M | $-6.5M |
| Income Tax Expense | — | — | — | — | — | — | $0 | $0 |
| Net Income | $874.0K | $-24.4M | $-23.1M | $-24.5M | $-19.8M | $-13.3M | $-16.1M | $-6.5M |
| Net Margin | 22.7% | -593.6% | -436.7% | -427.5% | -172.9% | -73.3% | -173.2% | -53.6% |
| EPS (Basic) | $0.02 | $-0.85 | $-0.88 | $-1.02 | $-0.84 | $-0.58 | $-0.73 | $-0.30 |
| EPS (Diluted) | $0.02 | $-0.85 | $-0.88 | $-1.02 | $-0.84 | $-0.58 | $-0.73 | $-0.30 |
| Shares Outstanding (Basic) | 29.1M | 25.6M | 26.3M | 24.0M | 23.5M | 21.9M | 22.0M | 21.8M |
| Shares Outstanding (Diluted) | 30.3M | 25.6M | 26.3M | 24.0M | 23.5M | 21.9M | 22.0M | 21.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |